Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eric Howard Greenberg Insider Profile
4 Followers
Eric Howard Greenberg, Director at Titan Pharmaceuticals, holds 66.25K shares in Titan Pharmaceuticals (Ticker: TTNP).
Eric Howard Greenberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Eric Howard Greenberg's holdings
Insider Roles
Director
Roles that Eric Howard Greenberg holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Eric Howard Greenberg
Eric Howard Greenberg's Trading History
List of latest transactions for each holding click on a transaction to see Eric Howard Greenberg's performance on stock
You May Also Like
Eric Howard Greenberg insider profile FAQ
What is the percentage of profitable transactions made by Eric Howard Greenberg?
The percentage of profitable transactions made by Eric Howard Greenberg is ―.
What is the average return per transaction made by Eric Howard Greenberg?
The average return per transaction made by Eric Howard Greenberg is ―.
What stocks does Eric Howard Greenberg hold?
Eric Howard Greenberg holds: TTNP stocks.
What was Eric Howard Greenberg’s latest transaction?
Eric Howard Greenberg latest transaction was an Uninformative Buy of ―.
What was Eric Howard Greenberg's most profitable transaction?
Eric Howard Greenberg’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Eric Howard Greenberg's role in Titan Pharmaceuticals?
Eric Howard Greenberg's role in Titan Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.